deoxyuridine triphosphate

Also Known As:
2'-deoxyuridine 5'-triphosphate; deoxy-UTP
Networked: 210 relevant articles (3 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Sung, Dong Kyung: 4 articles (02/2013 - 04/2009)
2. Chang, Yun Sil: 4 articles (02/2013 - 04/2009)
3. Park, Won Soon: 4 articles (02/2013 - 04/2009)
4. Li, Aihong: 3 articles (11/2013 - 01/2013)
5. Lin, Mao-Tsun: 3 articles (06/2010 - 01/2008)
6. Shimizu, Hiroaki: 2 articles (07/2015 - 03/2004)
7. Chen, Jie: 2 articles (02/2015 - 12/2012)
8. Hristova, Mariya: 2 articles (01/2015 - 07/2011)
9. Gressens, Pierre: 2 articles (01/2015 - 01/2011)
10. Bainbridge, Alan: 2 articles (01/2015 - 07/2011)

Related Diseases

1. B-Cell Lymphoma (Lymphoma, B Cell)
02/01/2015 - "Fetal renal B-cell lymphoma 2 (BCL-2) was decreased accompanied with higher 2'-deoxyuridine 5'-triphosphate nick end-labeling staining and unchanged soluble FAS in the hypoxia group. "
10/01/2011 - "Cilostazol reduced the infarct size, and the number of terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL)-positive apoptotic and B-cell lymphoma 2-associated X protein (Bax)-positive cells, and improved the CBF in control rats. "
05/01/2010 - "AG490-treated livers showed fewer cells positive for terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling and reduced cleaved caspase-3 protein expression in parallel with increased B-cell lymphoma extra large expression. "
02/01/2011 - "Although Ad-HO-1/BMMs decreased the frequency of apoptotic cells positive for terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling and ameliorated caspase-3 activity, the expression of interleukin-10 and antiapoptotic B cell lymphoma 2/B cell lymphoma extra large increased in well-functioning OLT. "
07/01/1997 - "We studied the apoptosis-proliferation ratio in various lymphoproliferative disorders in the skin, including mycosis fungoides (MF), cutaneous T-cell lymphoma showing solid tumor mass (CTCL), B-cell lymphoma of the skin (BCL), lymphomatoid papulosis (LyP), and cutaneous pseudolymphoma by using terminal deoxyuridine triphosphate (dUTP)-biotin nick end labeling (TUNEL), a newly developed method to detect internucleosomal breaks characteristic of apoptotic cells. "
2. Inflammation
04/01/2008 - "We observed that combined SCI and kaolin injection significantly increased the number of terminal deoxytransferase-mediated deoxyuridine triphosphate nick-end labeled-positive cells at 7 days after injury (p<0.05 compared with SCI alone) and resulted in a significantly greater extent of astrogliosis and macrophage/microglial-associated inflammation at the lesion (p<0.05). "
03/01/2005 - "OPN expression positively correlated with the degree of interstitial inflammation (P < 0.05), CD68+ monocyte infiltration (P < 0.01), Ki-67+ regenerating tubular and interstitial cells (P < 0.05 and P < 0.005, respectively), but not with terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL)-positive apoptotic tubular cells. "
06/01/2010 - "The number of terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick-end label-positive (TUNEL(+)) osteoclasts significantly increased on the surface of post-tooth extraction alveolar bone of the VitD(-)/ZOL group, where sustained inflammation was depicted by [(18)F]fluorodeoxyglucose micro-positron emission tomography (microPET). "
11/01/2011 - "Markers of mitochondrial damage (plasma cytochrome c), inflammation (myeloperoxidase), and apoptosis (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling) were analyzed. "
12/01/2007 - "Rabbit vaginal tissues were evaluated for localized cellular inflammation and in situ apoptosis by immunohistochemical staining for CD45, nuclear factor (NF)-kappa B, and terminal deoxynucleotidyl transferase-mediated FITC-deoxyuridine triphosphate nick-end labeling (TUNEL) using confocal laser scanning microscopy (CLSM), respectively. "
3. Hyperoxia
4. Body Weight (Weight, Body)
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
2. Kaolin
3. cilostazol (Pletal)
4. Biotin (Vitamin H)
5. Caspase 3 (Caspase-3)
6. Annexin A5
7. Fas Ligand Protein (Fas Ligand)
8. Fluorescein (Funduscein)
9. Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
10. thiazolyl blue

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Intraperitoneal Injections
3. Catheters
4. Transplantation (Transplant Recipients)
5. Tooth Extraction (Tooth Extractions)